UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2015-10, Vol.50 (10), p.1331-1336

2015

Volltextzugriff (PDF)

Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2017-10, Vol.52 (10), p.1436-1442

2017

Volltextzugriff (PDF)

Prevalence of untreated and uncontrolled cardiovascular risk factors in survivors of allogeneic cell transplantation

Bone marrow transplantation (Basingstoke), 2021-01, Vol.56 (1), p.167-174

2021

Volltextzugriff (PDF)

Late relapse after stopping sorafenib in allogeneic hematopoietic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2019-05, Vol.54 (5), p.769-771

2019

Volltextzugriff (PDF)

Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation

Annals of hematology, 2015-11, Vol.94 (11), p.1899-1905

2015

Volltextzugriff (PDF)

Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011-10, Vol.46 (10), p.1357-1362

2011

Volltextzugriff (PDF)

Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study

Bone marrow transplantation (Basingstoke), 2017-12, Vol.52 (12), p.1686-1688

2017

Volltextzugriff (PDF)

Prognostic impact of iron parameters in patients undergoing allo-SCT

Bone marrow transplantation (Basingstoke), 2012-01, Vol.47 (1), p.60-64

2012

Volltextzugriff (PDF)

Kinetics of peripheral blood chimerism for surveillance of patients with leukemia and chronic myeloid malignancies after reduced-intensity conditioning allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2015-05, Vol.50 (5), p.743-745

2015

Volltextzugriff (PDF)

Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011-03, Vol.46 (3), p.344-349

2011

Volltextzugriff (PDF)

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Current oncology (Toronto), 2020-12, Vol.27 (6), p.e596-606

2020

Volltextzugriff (PDF)

Pre-emptive diagnosis and treatment of fungal infections—evaluation of a single-centre policy

Clinical microbiology and infection, 2012-02, Vol.18 (2), p.189-194

2012

Volltextzugriff (PDF)

Prognostic impact of iron parameters in patients undergoing allo-SCT

Bone marrow transplantation (Basingstoke), 2012-04, Vol.47 (4), p.616

2012

Volltextzugriff (PDF)

Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT

Bone marrow transplantation (Basingstoke), 2011-05, Vol.46 (5), p.740-746

2011

Volltextzugriff (PDF)

Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT

Bone marrow transplantation (Basingstoke), 2013-03, Vol.48 (3), p.408-413

2013

Volltextzugriff (PDF)

Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma

Bone marrow transplantation (Basingstoke), 2005-12, Vol.36 (11), p.963-969

2005

Volltextzugriff (PDF)

High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML

Bone marrow transplantation (Basingstoke), 2011-05, Vol.46 (5), p.636-640

2011

Volltextzugriff (PDF)

Exploring Stem Cell Transplanted Patients' Perspectives on Medication Self-Management and Electronic Monitoring Devices Measuring Medication Adherence: A Qualitative Sub-Study of the Swiss SMILe Implementation Science Project

Patient preference and adherence, 2022-01, Vol.16, p.11-22

2022

Volltextzugriff (PDF)

Early-stage breast cancer - strategies for adjuvant systemic therapy

Handchirurgie, Mikrochirurgie, plastische Chirurgie, 2008-08, Vol.40 (4), p.230

2008

Volltextzugriff (PDF)

Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma

Cytotherapy (Oxford, England), 2021-04, Vol.23 (4), p.329-338

2021

Volltextzugriff (PDF)

Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma

Annals of oncology, 2005-04, Vol.16 (4), p.611-617

2005

Volltextzugriff (PDF)

Optic neuritis after influenza vaccination in a patient after stem cell transplantation

Klinische Monatsblatter fur Augenheilkunde, 2015-04, Vol.232 (4), p.484

2015

Volltextzugriff (PDF)

Angiogenic markers in plasma cell myeloma patients treated with novel agents

Anticancer research, 2015-02, Vol.35 (2), p.1085-1090

2015

Volltextzugriff (PDF)

Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner

Swiss medical weekly, 2012-10, Vol.142, p.w13696

2012

Volltextzugriff (PDF)

1 – 25 von 408

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(352)
Mit Volltextzugriff
(314)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(368)
Deutsch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation

Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation

Prevalence of untreated and uncontrolled cardiovascular risk factors in survivors of allogeneic cell transplantation

Late relapse after stopping sorafenib in allogeneic hematopoietic stem cell transplant recipients

Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation

Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT

Lack of association between relationship status and clinical outcome in allogeneic stem cell transplantation-the Swiss Transplant Cohort Study

Prognostic impact of iron parameters in patients undergoing allo-SCT

Kinetics of peripheral blood chimerism for surveillance of patients with leukemia and chronic myeloid malignancies after reduced-intensity conditioning allogeneic hematopoietic SCT

Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Pre-emptive diagnosis and treatment of fungal infections—evaluation of a single-centre policy

Prognostic impact of iron parameters in patients undergoing allo-SCT

Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT

Allo-SCT for multiple myeloma in the era of novel agents: a retrospective study on behalf of Swiss Blood SCT

Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma

High-dose melphalan with or without stem cell support before myeloablative allo-SCT for remission induction in patients with advanced relapsed or refractory AML

Exploring Stem Cell Transplanted Patients' Perspectives on Medication Self-Management and Electronic Monitoring Devices Measuring Medication Adherence: A Qualitative Sub-Study of the Swiss SMILe Implementation Science Project

Early-stage breast cancer - strategies for adjuvant systemic therapy

Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma

Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma

Optic neuritis after influenza vaccination in a patient after stem cell transplantation

Angiogenic markers in plasma cell myeloma patients treated with novel agents

Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation

Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner

Suchergebnisse filtern